Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Factors associated with long-term oral hypoglycemic agent responsiveness in korean patients with type 2 diabetes mellitus.

Kim BY, Jung CH, Mok JO, Kim CH.

Diabetes Metab J. 2011 Jun;35(3):282-9. doi: 10.4093/dmj.2011.35.3.282. Epub 2011 Jun 30.

2.

Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.

Lee SW, Lee S, Kim SH, Kim TH, Kang BS, Yoo SH, Lee MK, Koh WJ, Kang WS, Kim HJ.

Yonsei Med J. 2011 Nov;52(6):939-47. doi: 10.3349/ymj.2011.52.6.939.

3.

Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes.

Shim WS, Kim SK, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS.

Eur J Endocrinol. 2006 Oct;155(4):615-22.

5.
6.

Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care.

Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE.

Eur J Epidemiol. 2004;19(6):541-5.

PMID:
15330126
7.

Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial.

Weiss SR, Cheng SL, Kourides IA, Gelfand RA, Landschulz WH; Inhaled Insulin Phase II Study Group.

Arch Intern Med. 2003 Oct 27;163(19):2277-82.

PMID:
14581245
8.

Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.

Madsbad S, Kilhovd B, Lager I, Mustajoki P, Dejgaard A; Scandinavian Repaglinide Group.

Diabet Med. 2001 May;18(5):395-401.

PMID:
11472451
9.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
10.

Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy.

Fujiwara D, Takahashi K, Suzuki T, Shii M, Nakashima Y, Takekawa S, Yoshida A, Matsuoka T.

J Diabetes Investig. 2013 Nov 27;4(6):618-25. doi: 10.1111/jdi.12103. Epub 2013 May 30.

11.

Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.

Savage S, Estacio RO, Jeffers B, Schrier RW.

Proc Assoc Am Physicians. 1997 Mar;109(2):181-9.

PMID:
9069587
12.

C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus.

Juang JH, Huang HS, Huang MJ.

J Formos Med Assoc. 1992 May;91(5):491-6.

PMID:
1358326
13.
14.

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.

Gougeon R, Styhler K, Morais JA, Jones PJ, Marliss EB.

Diabetes Care. 2000 Jan;23(1):1-8.

15.

Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels.

Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W.

Diabetes Res Clin Pract. 1999 Oct;46(1):23-7.

PMID:
10580612
16.
17.

Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.

Pontiroli AE, Calderara A, Maffi P, Bonisolli L, Carenini A, Piatti PM, Monti LD, Gallus G, Pozza G, Illeni MT.

Diabete Metab. 1989 Mar-Apr;15(2):79-84.

PMID:
2661281
18.

Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.

Umpaichitra V, Banerji MA, Castells S.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):853-64.

PMID:
15270403
19.

Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients.

Kim BY, Jung CH, Mok JO, Kang SK, Kim CH.

Acta Diabetol. 2012 Feb;49(1):9-15. doi: 10.1007/s00592-010-0249-6. Epub 2011 Jan 7.

PMID:
21212993
20.

Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.

Diabetes Care. 1998 Jan;21(1):76-9.

PMID:
9538973
Items per page

Supplemental Content

Write to the Help Desk